Cite

HARVARD Citation

    Sasada, S. et al. (2017). 64Cu-DOTA-trastuzumab PET imaging for HER2-specific primary lesions of breast cancer. Annals of oncology. pp. 2028-2029. [Online]. 
  
Back to record